REFERENCES
- Cierny G, Mader JT, Pennick JJ. A clinical staging system for adult osteomyelitis. Clin.Orthop. 2003; 414: 7–24
- Simpson AH, Deakin M, Latham JM. Chronic osteomyelitis. The effect of the extent of surgical resection on infection-free survival. Bone Joint Surg. 2001; 83-B: 403–407
- Lazzarini L, Mader JT, Calhoun JH. Osteomyelitis in long bones. Bone Joint Surg. 2003; 86-A: 2305–2318
- Kawanabe K, Okad Y, Matsusue Y, Iida H, Nakamura T. Treatment of osteomyelitis with antibiotic soaked porous glass ceramic. J. Bone Joint Surg. Br. 1998; 80: 527–530
- Nikura T, Tsujimoto K, Yoshiya S, Takodoro K, Kurosaka R, Shiba T. Vancomycin-impregnated calcium phosphate cement for methicillin-resistant Staphylococcus aureus femoral osteomyelitis. Ortopedics. 2007; 30(4)320–321
- Higashi S, Yamamuro T, Nakamura T, Ikada Y, Hyon SH, Jamshidi K. Polymer-hydroxyapatite composites for biodegradable bone filler. Biomaterials 1986; 7: 183–187
- McLaren AC. Alternative materials to acrylic bone cement for delivery of depot antibiotics in orthopaedic infections. Clin. Orthop. Relat. Res. 2004; 427: 101–106
- Garvin K, Feshuk C. Polylactide-polyglicolide antibiotic implants. Clin. Orthop. Relat. Res. 2005; 437: 105–110
- Veyries M.L, Couarraze G, Geiger S, Agnely F, Massias L, Kunzli B, Faurisson F, Rouveix B. Controlled release of vancomycin from Poloxamer 407 gels. Int. J. Pharm. 1999; 192: 183–193
- Sayin B, Calis S, Atilla B, Marangoz S, Hincal AA. Implantation of vancomycin microspheres in blend with human/rabbit bone grafts to infected bone defects. J. Microencap. 2006; 23: 553–556
- Daschner FD, Kroper A. Glycopeptides in the treatment of staphylococcal infections. Eur. J. Clin. Microbiol. Infect. Dis. 1995; 14(Suppl. 1)S12–S17
- Perichon B, Courvalin P. Update on vancomycin resistance. Int. J. Clin. Pract. Suppl. 2000; 115: 88–93
- AK BangaTherapeutic Peptides and Proteins: Formulation, Processing, and Delivery Systems, . Technomic, Lancaster-Basel 1995
- Irie T, Uekama K. Cyclodextrins in peptide and protein delivery. Adv. Drug Deliv. Rev. 1999; 36: 101–123
- Matsubara K, Irie T, Uekama K. Controlled release of LHRH agonist buserelin acetate from injectable suspensions containing triacetylated cyclodextrins in an oil vehicle. J. Control. Release. 1994; 31: 173–180
- Uekama K, Arima H, Irie T, Matsubara K, Kuriki T. Sustained release of buserelin acetate, a luteinizing hormone-releasing hormone agonist, from an injectable oily preparation utilizing ethylated β-cyclodextrin. J. Pharm. Pharmacol. 1999; 41: 874–876
- Mura P, Bettinetti GP, Manderiol A, Faucci MT, Bramanti G, Sorrenti M. Interactions of ketoprofen and ibuprofen with ß-cyclodextrins in solution and in the solid state. Int. J. Pharm. 1998; 166: 189–203
- Luksa J, Marusic A. Rapid high-performance liquid chromatographic determination of vancomycin in human plasma. J. Chrom. B. 1995; 667: 277–281
- Edmunson IC. Particle size analysis. Adv. Pharm. Sci. 1967; 2: 95–179
- Nash AR. J Swarbrick, J BoylanSuspensions. Encyclopedia of Pharmaceutical Technology.2nd, . Marcel Dekker, New York 2002; 2654–2667
- Rossi S, Sandri G, Ferrari F, Bonferoni MC, Caramella C. Development of films and matrices based on chitosan and polyacrylic acid for vaginal delivery of acyclovir. STP Pharma Sci. 2003; 13: 183–190